This study also showed that DHA supplementation restrained expression of FoxO1 and FoxO3 in pig adipocytes and human kidney HEK293T cells, suggesting that FoxO are potential therapeutic targets for DHA in ameliorating metabolic syndromes. Here, FOXO1 is linked to metabolic syndrome.